Mirtazapine Tablet, Film Coated
Product Images NDC 57237-009

5 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 57237-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablet Bottle))

Package Label-principal Display Panel (7.5 mg (100 Tablet Bottle))
Label for Mirtazapine Tablets USP 7.5 mg film-coated tablets by Rising Pharma Holdings, Inc. The label states the quantity as 30 tablets and is marked Rx only. Additional information includes storage instructions at 25°C, dispensing instructions, manufacturer details, and a barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))
Label for Mirtazapine Tablets, USP 15 mg, film-coated oral tablets. The label states a package size of 30 tablets and includes dispensing instructions with a medication guide note. It is distributed by Rising Health, LLC, Saddle Brook, NJ, and manufactured in India. The label includes storage instructions and a barcode on the right.*
FDA Label Image

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))
Mirtazapine Tablets, USP 30 mg film-coated tablets packaging label by Rising Pharma Holdings, Inc. The label shows the product name, strength, and quantity of 30 tablets. It includes directions for dosage, storage conditions, and dispensing instructions. The product is distributed by Rising Health, LLC and is made in India, with an NDC number 57237-009-30 visible on the label.*
FDA Label Image

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))
Mirtazapine Tablets USP 45 mg film-coated oral tablets packaging label by Rising Pharma Holdings, Inc. The label shows the product name, strength, dosage form, quantity (30 tablets), pharmacist dispensing instructions, storage conditions, and distributor information (Rising Health, LLC). Barcode and manufacturing details (Made in India) are also visible.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure diagram of Mirtazapine, displaying its molecular ring system with nitrogen atoms and a methyl group as part of its chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.